Evidence map›Paper›PMID 33200047›Full record

ArticleTranslational vision science & technology2020

A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.

Ratnakar Tripathi, Praveen K Balne, Nishant R Sinha, Lynn M Martin, Sabeeh Kamil, James R Landreneau, Suneel Gupta, Jason T Rodier, Prashant R Sinha, Nathan P Hesemann and 4 more

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Fenofibrate microemulsion eyedrops for treating nitrogen mustard induced corneal injury.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Washing with buffered vitamin C after corrosive chemical (sodium hypochlorite) exposure reduces ocular depth of injury.Toxicology in vitro : an international journal published in association with BIBRA · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Carbofuran pesticide toxicity to the eye.Experimental eye research · 2023
    Review
  16. Corneal stromal repair and regeneration.Progress in retinal and eye research · 2022
    Review
  17. Article
  18. Article
  19. Effects of Regular/Dilute Proparacaine Anesthetic Eye Drops in Combination with Ophthalmic Antibiotics on Corneal Wound Healing.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ratnakar TripathiHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Praveen K BalneHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Nishant R SinhaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Lynn M MartinHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Sabeeh KamilHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
James R LandreneauHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Suneel GuptaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Jason T RodierHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Prashant R SinhaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Nathan P HesemannHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Alexandria C HofmannOne-Health Vision Research Program, Departments of Veterinary Medicine and Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA.
Michael K FinkHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Shyam S ChaurasiaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Rajiv R MohanHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA.
Missouri College · USHarry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri · US

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur MustardU01EY031650 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2020 to 2024
$3.7M
Role of S100 proteins in Diabetic RetinopathyR01EY029795 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHAURASIA, SHYAM SUNDER · 2019 to 2023
$2.2M
Novel approaches for corneal haze/fibrosis eliminationR01EY030774 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2019 to 2022
$1.5M
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur MustardR21EY030234 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2018 to 2019
$426k
Nanomedicine Approach to Counteract Acrolien-induced Blindness and Toxicity to the EyeR21EY030233 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHAURASIA, SHYAM SUNDER, GIULIANO, ELIZABETH · 2018 to 2019
$425k
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal DiseasesI01BX000357 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Rajiv Ravindra Mohan · 2009 to 2026
–
BLRD VA I01 BX000357BLRD VA IK6 BX005646NEI NIH HHS R01 EY017294NEI NIH HHS R01 EY029795NEI NIH HHS R01 EY030774NEI NIH HHS R21 EY030233NEI NIH HHS R21 EY030234NEI NIH HHS U01 EY031650
6 · The paper itself

Abstract

Purpose: This pilot study investigated the in vivo therapeutic potential and tolerability of a multimodal ophthalmic formulation, topical eye drops (TED), for acute mustard gas keratopathy (MGK) using a rabbit model. Methods: Twenty New Zealand White rabbits were used. Only right eyes of 18 rabbits (oculus dexter [OD]) received single sulfur mustard gas (SM) vapor injury, whereas contralateral eyes were left untreated or received TED for tolerabilty evaluation. Two rabbit eyes received no treatment and served as age-matched naive control. The four groups were: Naive (oculus sinister [OS] untreated eyes; n = 9); TED (OS treated only with TED BID for 3 days; n = 9); SM (OD exposed to SM vapor; n = 9); and SM+TED (OD exposed to SM+TED BID for 3 days; n = 9). Ocular examination in live rabbits were performed utilizing slit-lamp biomicroscopy, Fantes grading system, fluorescein staining, Schirmer's tests, pachymetry, and applanation tonometry. Cellular and molecular changes in rabbit corneas were assessed after humane euthanasia on day-3 and day-7 with histopathological and real-time polymerase chain reaction PCR techniques. Results: TED to rabbit eyes was found tolerable in vivo. SM-exposed eyes showed significant increase in Fantes scores, central corneal thickness (CCT), Schirmer's test, epithelium-stroma separation, and corneal edema. TED mitigated clinical symptoms by reducing corneal edema, Fantes scores, CCT, and Schirmer's test. Further, TED decreased SM-induced corneal haze, inflammatory and profibrotic markers, transforming growth factor-TGF-β1 and cyclooxygenase-2COX-2, and damage to corneal structure, including epithelial-stromal integrity. Conclusions: The developed multimodal eyedrop formulation, TED, has potential to mitigate acute MGK effectively in vivo. Translational Relevance: TED is effective against MGK.

Indexed as

Corneal DiseasesCorneal EdemaMustard GasAnimalsCorneaPilot ProjectsRabbitsMustard Gascorneacorneal edemaintraocular pressureocular inflammationsulfur mustard

Identifiers

PMID33200047
PMCPMC7645241
OpenAlexW3096739501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.